The impact of type 2 diabetes mellitus on mortality in hospitalized female cancer patients in Taiwan

Asia-Pacific Journal of Clinical Oncology

Volumn 12, Issue 1, 2016, Pages e75-e81

  Chen, Jeng Yeou ^a   Chiou, Wen Ko ^a   Chou, Wei Ying ^a   Lin, Jen Der ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Cancer mortality; Hepatoma; Hyperinsulinemia; Pancreatic cancer

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER MORTALITY; CANCER PATIENT; CHINESE; CONTROLLED STUDY; FEMALE; HEMATOLOGIC MALIGNANCY; HISTOPATHOLOGY; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; ICD-9; KIDNEY CANCER; LIVER CANCER; LUNG CANCER; MAJOR CLINICAL STUDY; MALIGNANT NEOPLASTIC DISEASE; NASOPHARYNX CANCER; NON INSULIN DEPENDENT DIABETES MELLITUS; OVARY CANCER; PANCREAS CANCER; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TAIWAN; THYROID CANCER; URINARY TRACT CANCER; UTERINE CERVIX CANCER; COMPLICATION; DIABETES MELLITUS, TYPE 2; HOSPITAL MORTALITY; INCIDENCE; MIDDLE AGED; MORTALITY; NEOPLASM; PROPORTIONAL HAZARDS MODEL;

ADULT; AGED; DIABETES MELLITUS, TYPE 2; FEMALE; HOSPITAL MORTALITY; HUMANS; INCIDENCE; MIDDLE AGED; NEOPLASMS; PROPORTIONAL HAZARDS MODELS; TAIWAN;

EID: 84878205879     PISSN: 17437555     EISSN: 17437563     Source Type: Journal    
DOI: 10.1111/ajco.12084     Document Type: Article

References (35)

1. Gannagé-Yared MH, Chedid R, Abs L. Relation between androgens and cardiovascular risk factors in a young population. Clin Endocrinol 2011; 74: 720-725.
2. Homko CJ, Zamora L, Santamore WP, Kashem A, McConnell T, Bove AA. Gender differences in cardiovascular risk factors and risk perception among individuals with diabetes. Diabetes Educ 2010; 36: 483-488.
3. Pal SK, Hurria A. Impact of age, sex, and comorbidity on cancer therapy and disease progression. J Clin Oncol 2010; 28: 4086-4093.
4. Koo JH, Leong RW. Sex differences in epidemiological, clinical and pathological characteristics of colorectal cancer. J Gastroenterol Hepatol 2010; 25: 33-42.
5. Conover CA, Lee PD, Kanaley JA, Clarkson JT, Jensen MD. Insulin regulation of insulin-like growth factor binding protein-1 in obese and nonobese humans. J Clin Endocrinol Metab 1992; 74: 1355-1360.
6. Khandwala HM, McCutcheon IE, Flyvbjerg A, Friend KE. The effects of insulin-like growth factors on tumorigenesis and neoplastic growth. Endocr Rev 2000; 21: 215-244.
7. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010; 33(Suppl. 1): S62-69.
8. Levesque R, SPSS. Programming and Data Management for SPSS 16.0: A Guide for SPSS and SAS Users. SPSS, Chicago IL 2007.
9. Yeh HC, Platz EA, Wang NY, Visvanathan K, Helzlsouer KJ, Brancati FL. A prospective study of the associations between treated diabetes and cancer outcomes. Diabetes Care 2012; 35: 113-118.
10. Ben Q, Cai Q, Li Z etal. The relationship between new-onset diabetes mellitus and pancreatic cancer risk: a case-control study. Eur J Cancer 2011; 47: 248-254.
11. Inoue M, Iwasaki M, Otani T, Sasazuki S, Noda M, Tsugane S. Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan. Arch Intern Med 2006; 166: 1871-1877.
12. Sella T, Chodick G, Barchana M etal. Gestational diabetes and risk of incident primary cancer: a large historical cohort study in Israel. Cancer Causes Control 2011; 22: 1513-1520.
13. Lee MY, Lin KD, Hsiao PJ, Shin SJ. The association of diabetes mellitus with liver, colon, lung, and prostate cancer is independent of hypertension, hyperlipidemia, and gout in Taiwanese patients. Metabolism 2012; 61: 242-249.
14. Chari ST, Leibson CL, Rabe KG, Ransom J, de Andrade M, Petersen GM. Probability of pancreatic cancer following diabetes: a population-based study. Gastroenterology 2005; 129: 504-511.
15. Chiou WK, Huang BY, Chou WY, Weng HF, Lin JD. Incidence of cancer in diabetic and non-diabetic hospitalized adult patients. Asian Pac J Cancer Prev 2011; 12: 1577-1581.
16. Larsson SC, Orsini N, Wolk A. Diabetes mellitus and risk of colorectal cancer: a meta-analysis. J Natl Cancer Inst 2005; 97: 1679-1687.
17. Pannala R, Leirness JB, Bamlet WR, Basu A, Petersen GM, Chari ST. Prevalence and clinical profile of pancreatic cancer-associated diabetes mellitus. Gastroenterology 2008; 134: 981-987.
18. Jamal MM, Yoon EJ, Vega KJ, Hashemzadeh M, Chang KJ. Diabetes mellitus as a risk factor for gastrointestinal cancer among American veterans. World J Gastroenterol 2009; 15: 5274-5278.
19. Chu CK, Mazo AE, Goodman M etal. Preoperative diabetes mellitus and long-term survival after resection of pancreatic adenocarcinoma. Ann Surg Oncol 2010; 17: 502-513.
20. Larsson SC, Wolk A. Diabetes mellitus and incidence of kidney cancer: a meta-analysis of cohort studies. Diabetologia 2011; 54: 1013-1018.
21. Washio M, Mori M, Khan M etal. Diabetes mellitus and kidney cancer risk: the results of Japan Collaborative Cohort Study for Evaluation of Cancer Risk (JACC Study). Int J Urol 2007; 14: 393-397.
22. Woolcott CG, Maskarinec G, Haiman CA, Henderson BE, Kolonel LN. Diabetes and urothelial cancer risk: the multiethnic cohort study. Cancer Epidemiol 2011; 35: 551-554.
23. MacKenzie T, Zens MS, Ferrara A, Schned A, Karagas MR. Diabetes and risk of bladder cancer: evidence from a case-control study in New England. Cancer 2011; 117: 1552-1556.
24. Ettinger DS, Aisner J. Changing face of small-cell lung cancer: real and artifact. J Clin Oncol 2006; 24: 4526-4527.
25. Zang EA, Wynder EL. Differences in lung cancer risk between men and women: examination of the evidence. J Natl Cancer Inst 1996; 88: 183-192.
26. Kuriki K, Hirose K, Tajima K. Diabetes and cancer risk for all and specific sites among Japanese men and women. Eur J Cancer Prev 2007; 16: 83-89.
27. Ehrlich SF, Quesenberry CP Jr, Van Den Eeden SK, Shan J, Ferrara A. Patients diagnosed with diabetes are at increased risk for asthma, chronic obstructive pulmonary disease, pulmonary fibrosis, and pneumonia but not lung cancer. Diabetes Care 2010; 33: 55-60.
28. Xue F, Michels KB. Diabetes, metabolic syndrome, and breast cancer: a review of the current evidence. Am J Clin Nutr 2007; 86: S823-835.
29. Michels KB, Terry KL, Willett WC. Longitudinal study on the role of body size in premenopausal breast cancer. Arch Intern Med 2006; 166: 2395-2402.
30. Paes JE, Hua K, Nagy R, Kloos RT, Jarjoura D, Ringel MD. The relationship between body mass index and thyroid cancer pathology features and outcomes: a clinicopathological cohort study. J Clin Endocrinol Metab 2010; 95: 4244-4250.
31. Aschebrook-Kilfoy B, Sabra MM, Brenner A etal. Diabetes and thyroid cancer risk in the National Institutes of Health-AARP Diet and Health Study. Thyroid 2011; 21: 957-963.
32. Mijović T, How J, Pakdaman M etal. Body mass index in the evaluation of thyroid cancer risk. Thyroid 2009; 19: 467-472.
33. Cleveland RJ, North KE, Stevens J, Teitelbaum SL, Neugut AI, Gammon MD. The association of diabetes with breast cancer incidence and mortality in the Long Island Breast Cancer Study Project. Cancer Causes Control 2012; 23: 1193-1203.
34. Romero IL, McCormick A, McEwen KA etal. Relationship of type II diabetes and metformin use to ovarian cancer progression, survival, and chemosensitivity. Obstet Gynecol 2012; 119: 61-67.
35. Chen WW, Shao YY, Shau WY etal. The impact of diabetes mellitus on prognosis of early breast cancer in Asia. Oncologist 2012; 17: 485-491.